Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health In Tech (HIT) Liabilities and Shareholders Equity (2023 - 2025)

Historic Liabilities and Shareholders Equity for Health In Tech (HIT) over the last 3 years, with Q3 2025 value amounting to $22.8 million.

  • Health In Tech's Liabilities and Shareholders Equity changed N/A to $22.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $82.0 million, marking a year-over-year increase of 61312.44%. This contributed to the annual value of $15.8 million for FY2024, which is 3707.81% up from last year.
  • Per Health In Tech's latest filing, its Liabilities and Shareholders Equity stood at $22.8 million for Q3 2025.
  • Over the past 5 years, Health In Tech's Liabilities and Shareholders Equity peaked at $22.8 million during Q3 2025, and registered a low of $11.5 million during Q4 2023.
  • Moreover, its 3-year median value for Liabilities and Shareholders Equity was $21.3 million (2025), whereas its average is $18.7 million.
  • Data for Health In Tech's Liabilities and Shareholders Equity shows a peak YoY increase of 3707.81% (in 2024) and a maximum YoY decrease of 3707.81% (in 2024) over the last 5 years.
  • Quarter analysis of 3 years shows Health In Tech's Liabilities and Shareholders Equity stood at $11.5 million in 2023, then skyrocketed by 37.08% to $15.8 million in 2024, then soared by 44.31% to $22.8 million in 2025.
  • Its last three reported values are $22.8 million in Q3 2025, $22.2 million for Q2 2025, and $21.3 million during Q1 2025.